The interaction of p66Shc with oncogenic factors, such as Aurora‐A, enhances Slug activity, suggesting crosstalk with critical oncogenic pathways that strengthens its potential as a therapeutic target in CRC [97, 99]. The gene discussed is SNAI2; the disease is colorectal carcinoma.